APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,159,712 | -52.1% | 1,003,147 | +14.7% | 0.01% | -43.8% |
Q2 2023 | $79,691,729 | +108.5% | 874,772 | +51.0% | 0.02% | +77.8% |
Q1 2023 | $38,221,182 | +50.8% | 579,460 | +18.2% | 0.01% | +80.0% |
Q4 2022 | $25,346,639 | +7.1% | 490,169 | +41.4% | 0.01% | 0.0% |
Q3 2022 | $23,677,000 | +18.0% | 346,661 | -21.9% | 0.01% | 0.0% |
Q2 2022 | $20,067,000 | -44.7% | 443,759 | -37.9% | 0.01% | -37.5% |
Q1 2022 | $36,286,000 | -38.7% | 714,152 | -43.0% | 0.01% | -33.3% |
Q4 2021 | $59,215,000 | -35.3% | 1,252,431 | -54.9% | 0.01% | -36.8% |
Q3 2021 | $91,511,000 | +168.3% | 2,776,432 | +414.4% | 0.02% | +171.4% |
Q2 2021 | $34,110,000 | +446.1% | 539,716 | +270.8% | 0.01% | +250.0% |
Q1 2021 | $6,246,000 | -92.7% | 145,552 | -90.3% | 0.00% | -90.9% |
Q4 2020 | $85,471,000 | +26.6% | 1,494,246 | -33.2% | 0.02% | +15.8% |
Q3 2020 | $67,486,000 | +43.6% | 2,236,858 | +55.5% | 0.02% | +11.8% |
Q2 2020 | $46,981,000 | +101.4% | 1,438,460 | +65.2% | 0.02% | +70.0% |
Q1 2020 | $23,331,000 | +19.9% | 870,840 | +37.0% | 0.01% | +25.0% |
Q4 2019 | $19,461,000 | +19.7% | 635,560 | -1.0% | 0.01% | +14.3% |
Q2 2019 | $16,261,000 | -11.8% | 641,720 | -32.1% | 0.01% | -22.2% |
Q1 2019 | $18,431,000 | +2679.9% | 945,184 | +1780.3% | 0.01% | – |
Q4 2018 | $663,000 | -41.4% | 50,269 | -21.1% | 0.00% | -100.0% |
Q3 2018 | $1,132,000 | +358.3% | 63,712 | +465.5% | 0.00% | – |
Q2 2018 | $247,000 | – | 11,267 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |